We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Unapproved-Use Communication Rules Prompt First Amendment Worries
FDA’s Unapproved-Use Communication Rules Prompt First Amendment Worries
An FDA memo outlining restrictions on communications over unapproved uses could restrict the flow of important information, and conflict with a company’s freedom of speech, say drugmakers and industry groups.